| 2021-03-15 | Sale | Marinus Pharmaceuticals, Inc. MRNS | director | 4,250 0.0117% | $15.87 | $67,448 | -21.73% | |
| 2019-03-19 | Sale | Esperion Therapeutics, Inc. ESPR | director | 15,329 0.0581% | $44.73 | $685,596 | +1.25% | |
| 2018-01-25 | Sale | Esperion Therapeutics, Inc. ESPR | director | 23,348 0.0862% | $71.79 | $1.68M | -36.4% | |
| 2017-12-06 | Sale | Esperion Therapeutics, Inc. ESPR | director | 18,652 0.079% | $53.85 | $1M | -6.34% | |
| 2013-07-01 | Esperion Therapeutics, Inc. ESPR | 571,428 3.7236% | $14.00 | $8M | +8.67% | |||
| 2011-06-02 | Sale | Alimera Sciences, Inc. ALIM | 10 percent owner | 13,828 0.044% | $8.04 | $111,177 | -53.11% | |
| 2010-04-27 | Alimera Sciences, Inc. ALIM | 10 percent owner | 756,056 3.1079% | $11.00 | $8.32M | -17.39% | ||
| 2006-12-12 | Sale | Vanda Pharmaceuticals Inc. VNDA | 10 percent owner | 25,800 0.1648% | $25.62 | $660,996 | -19.11% |